By Elsa Ohlen
Drugstore chain Walgreens Boots Alliance is nearing a deal to be bought by private-equity firm Sycamore for roughly $10 billion, a report says.
Walgreens stock rose 6.6% to $10.94 in premarket trading.
A deal price of between $11.30 and $11.40 a share in cash has been discussed and a deal could be reached as soon as Thursday, The Wall Street Journal reported late Monday, citing people familiar with the matter.
Walgreens didn't immediately respond to a request for comment early on Tuesday.
If Sycamore ends up completing the buyout it is expected to maintain the Walgreens U.S. retail business but sell or take public the remaining parts of the company, according to The Wall Street Journal.
Walgreens shares are down 51% over the last 12 months. The stock peaked a decade ago with a market value of more than $100 billion.
Write to Elsa Ohlen at elsa.ohlen@barrons.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 04, 2025 05:26 ET (10:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。